Investing in Japan
Investment News
Feb. 28, 2008
Medical Equipment: How U.S. Companies Are Positioned to Get Ahead of Two Upcoming Shifts in Japan （produced by JETRO USA)
Two upcoming shifts in Japan's healthcare sector can create opportunities for U.S. companies who can meet changing needs and work within Japan's dealer distribution system.
The first shift comes from the increase in Japan's senior population, which is expected to grow demand for artificial internal organs, such as pacemakers and artificial joints. U.S. companies currently own nearly 100% of the artificial internal organ market in Japan. The Japanese medical equipment industry has traditionally shied away from producing such high risk equipment, says Hiro Katsuse, JETRO healthcare advisor, and thus looks to the U.S. to fill the need. Although this sector is more challenging to enter due to the high risk usually associated with such products, the expected increase in demand could provide an opportunity for new entrants into the market.
To read the full report, please visit the JETRO US website
.
